Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Myriad Genetics

Founders Mark Skolnick Peter D. Meldrum Walter Gilbert

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$20M
Portfolio companies 1
Rounds per year 0.03
Lead investments 0
Exits 1
Key employees Soon

Areas of investment

  • Genetics
  • Biotechnology
  • Health Care
  • Health Diagnostics
Summary

In 1991 was created Myriad Genetics, which is appeared as Corporate Investor. The company was established in North America in United States. The main office of represented Corporate Investor is situated in the Salt Lake City.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight RainDance Technologies. Among the most popular fund investment industries, there are Biotechnology, Health Care.

The typical case for the fund is to invest in rounds with 6 participants. Despite the Myriad Genetics, startups are often financed by Quaker BioVentures, Mohr Davidow Ventures, Alloy Ventures. The meaningful sponsors for the fund in investment in the same round are Sectoral Asset Management, Quaker BioVentures, Mohr Davidow Ventures. In the next rounds fund is usually obtained by Northgate Capital, GE Ventures, CRG L.P..

The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2017. The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2013.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Ace Capital Partners France, Ile-de-France, Paris
Cancer Prevention and Research Institute of Texas Austin, Texas, United States
Capital Z Partners New York, New York, United States
Elemental Energy -
Granatus Ventures Armenia, Yerevan
incTANK Ventures Cambridge, Massachusetts, United States
Ivy Capital China, Shanghai
Qixi Investment -
Xintuo Information Technology China, Hangzhou, Zhejiang

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Myriad Genetics?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 20M
Rounds per year 0.03
Peak activity year 2013
Lead investments 0
Exits 1
Group Appearance index 1.00
Crunchbase icon

Content report

The following text will be sent to our editors: